Search

everythinglearnresearchcommunity

for

Search:↓

Hair growth dysfunction involves various conditions with limited treatment options.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

A 13-year-old boy had a rare, stable type of hair loss with little chance of regrowth, but treatment is available for looks.

Early treatment of children's hair loss, which can be caused by various factors, is important due to its emotional impact.

Trichotillomania is a disorder where people compulsively pull out their hair, treated with drugs and behavior therapy.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document concludes that terbinafine is effective for treating scalp fungal infections in children and recommends not excluding them from school during treatment, while also highlighting the need for updated treatment guidelines due to changing infection patterns.

Tinea capitis can be misdiagnosed as bacterial infection in adult women but is treatable with antifungal medication.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Children's hair loss can be caused by many factors, including autoimmune diseases, emotional stress, genetics, and infections, with treatment and prognosis varying.

A family showed a new condition with inherited hair loss and skin changes, possibly due to one genetic disorder.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

The document concludes that scalp conditions have various causes and can present in many different ways.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Primary idiopathic pseudopelade of Brocq causes gradual, scarring hair loss with no effective treatment.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

New understanding and treatments for hair loss are improving, but more research is needed.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

Leukemia can sometimes appear as unusual skin issues in children.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Trichotillomania treatment is most successful with a mix of behavioral therapy, medication, and social support.

Injecting fillers in the temple can cause serious complications, but the damage can be treated if managed properly.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.